MAPK7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.373600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.275990E-02
Normal-vs-Stage2
4.043600E-01
Normal-vs-Stage3
9.706100E-02
Normal-vs-Stage4
4.956400E-01
Stage1-vs-Stage2
9.821700E-03
Stage1-vs-Stage3
5.901400E-01
Stage1-vs-Stage4
1.769810E-01
Stage2-vs-Stage3
1.612990E-01
Stage2-vs-Stage4
9.126200E-01
Stage3-vs-Stage4
2.535000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.367400E-01
Normal-vs-AfricanAmerican
1.060790E-01
Normal-vs-Asian
6.334000E-01
Caucasian-vs-AfricanAmerican
6.070200E-01
Caucasian-vs-Asian
4.668200E-01
AfricanAmerican-vs-Asian
3.781200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.233600E-01
Normal-vs-Female
4.809000E-01
Male-vs-Female
1.844850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.806200E-02
Normal-vs-Age(41-60Yrs)
5.503200E-01
Normal-vs-Age(61-80Yrs)
2.756600E-01
Normal-vs-Age(81-100Yrs)
2.838400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.786100E-04
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.146300E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.923800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.609800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.023200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.355000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.415000E-01
Normal-vs-Daily Drinker
2.283000E-01
Normal-vs-Weekly Drinker
8.812600E-01
Normal-vs-Occasional Drinker
9.266100E-02
Normal-vs-Social Drinker
1.094380E-01
Non Drinker-vs-Daily Drinker
9.364200E-01
Non Drinker-vs-Weekly Drinker
2.984000E-02
Non Drinker-vs-Occasional Drinker
8.384200E-01
Non Drinker-vs-Social Drinker
7.129600E-01
Daily Drinker-vs-Weekly Drinker
4.258300E-02
Daily Drinker-vs-Occasional Drinker
9.191200E-01
Daily Drinker-vs-Social Drinker
8.074000E-01
Weekly Drinker-vs-Occasional Drinker
6.627700E-02
Weekly Drinker-vs-Social Drinker
8.059800E-02
Occasional Drinker-vs-Social Drinker
8.459200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.338400E-01
Normal-vs-Grade 2
8.191200E-01
Normal-vs-Grade 3
7.620800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.020080E-02
Grade 1-vs-Grade 3
2.827800E-01
Grade 1-vs-Grade 4
7.338400E-01
Grade 2-vs-Grade 3
1.973740E-02
Grade 2-vs-Grade 4
8.191200E-01
Grade 3-vs-Grade 4
7.620800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.988600E-01
Normal-vs-NonDiabetic
3.905600E-01
Diabetic-vs-NonDiabetic
5.793800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.945400E-01
Normal-vs-NoPancreatitis
2.905600E-01
Pancreatitis-vs-NoPancreatitis
5.039400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.672640E-01
Normal-vs-N1
4.156800E-01
N0-vs-N1
3.834400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.808400E-01
Normal-vs-TP53-NonMutant
1.773960E-01
TP53-Mutant-vs-TP53-NonMutant
9.380000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
